Clinical Biomarker Testing Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1551421 No. of Pages: 63 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
This report aims to provide a comprehensive presentation of the global market for Clinical Biomarker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Biomarker Testing. This report contains market size and forecasts of Clinical Biomarker Testing in global, including the following market information:
Global Clinical Biomarker Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Clinical Biomarker Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical Biomarker Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Biomarker Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Clinical Biomarker Testing Market Segment Percentages, by Type, 2022 (%)
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease
Global Clinical Biomarker Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Clinical Biomarker Testing Market Segment Percentages, by Application, 2022 (%)
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Global Clinical Biomarker Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Clinical Biomarker Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Biomarker Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Clinical Biomarker Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Biomarker Testing, market overview.
Chapter 2: Global Clinical Biomarker Testing market size in revenue.
Chapter 3: Detailed analysis of Clinical Biomarker Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Biomarker Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Clinical Biomarker Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Clinical Biomarker Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Clinical Biomarker Testing Overall Market Size
2.1 Global Clinical Biomarker Testing Market Size: 2022 VS 2029
2.2 Global Clinical Biomarker Testing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Clinical Biomarker Testing Players in Global Market
3.2 Top Global Clinical Biomarker Testing Companies Ranked by Revenue
3.3 Global Clinical Biomarker Testing Revenue by Companies
3.4 Top 3 and Top 5 Clinical Biomarker Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Clinical Biomarker Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Biomarker Testing Players in Global Market
3.6.1 List of Global Tier 1 Clinical Biomarker Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Clinical Biomarker Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Clinical Biomarker Testing Market Size Markets, 2022 & 2029
4.1.2 Cancer
4.1.3 Metabolism
4.1.4 Infectious Disease
4.1.5 Cardiology
4.1.6 Neurology
4.1.7 Immunological Disease
4.2 By Type - Global Clinical Biomarker Testing Revenue & Forecasts
4.2.1 By Type - Global Clinical Biomarker Testing Revenue, 2018-2023
4.2.2 By Type - Global Clinical Biomarker Testing Revenue, 2024-2029
4.2.3 By Type - Global Clinical Biomarker Testing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Clinical Biomarker Testing Market Size, 2022 & 2029
5.1.2 Drug Discovery
5.1.3 Nutrigenomics
5.1.4 Toxicology Testing
5.1.5 Personalized Medicine
5.1.6 Functional Genomics
5.2 By Application - Global Clinical Biomarker Testing Revenue & Forecasts
5.2.1 By Application - Global Clinical Biomarker Testing Revenue, 2018-2023
5.2.2 By Application - Global Clinical Biomarker Testing Revenue, 2024-2029
5.2.3 By Application - Global Clinical Biomarker Testing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Clinical Biomarker Testing Market Size, 2022 & 2029
6.2 By Region - Global Clinical Biomarker Testing Revenue & Forecasts
6.2.1 By Region - Global Clinical Biomarker Testing Revenue, 2018-2023
6.2.2 By Region - Global Clinical Biomarker Testing Revenue, 2024-2029
6.2.3 By Region - Global Clinical Biomarker Testing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Clinical Biomarker Testing Revenue, 2018-2029
6.3.2 US Clinical Biomarker Testing Market Size, 2018-2029
6.3.3 Canada Clinical Biomarker Testing Market Size, 2018-2029
6.3.4 Mexico Clinical Biomarker Testing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Clinical Biomarker Testing Revenue, 2018-2029
6.4.2 Germany Clinical Biomarker Testing Market Size, 2018-2029
6.4.3 France Clinical Biomarker Testing Market Size, 2018-2029
6.4.4 U.K. Clinical Biomarker Testing Market Size, 2018-2029
6.4.5 Italy Clinical Biomarker Testing Market Size, 2018-2029
6.4.6 Russia Clinical Biomarker Testing Market Size, 2018-2029
6.4.7 Nordic Countries Clinical Biomarker Testing Market Size, 2018-2029
6.4.8 Benelux Clinical Biomarker Testing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Clinical Biomarker Testing Revenue, 2018-2029
6.5.2 China Clinical Biomarker Testing Market Size, 2018-2029
6.5.3 Japan Clinical Biomarker Testing Market Size, 2018-2029
6.5.4 South Korea Clinical Biomarker Testing Market Size, 2018-2029
6.5.5 Southeast Asia Clinical Biomarker Testing Market Size, 2018-2029
6.5.6 India Clinical Biomarker Testing Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Clinical Biomarker Testing Revenue, 2018-2029
6.6.2 Brazil Clinical Biomarker Testing Market Size, 2018-2029
6.6.3 Argentina Clinical Biomarker Testing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Clinical Biomarker Testing Revenue, 2018-2029
6.7.2 Turkey Clinical Biomarker Testing Market Size, 2018-2029
6.7.3 Israel Clinical Biomarker Testing Market Size, 2018-2029
6.7.4 Saudi Arabia Clinical Biomarker Testing Market Size, 2018-2029
6.7.5 UAE Clinical Biomarker Testing Market Size, 2018-2029
7 Clinical Biomarker Testing Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Clinical Biomarker Testing Major Product Offerings
7.1.4 Abbott Laboratories Clinical Biomarker Testing Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 AbbVie Inc.
7.2.1 AbbVie Inc. Company Summary
7.2.2 AbbVie Inc. Business Overview
7.2.3 AbbVie Inc. Clinical Biomarker Testing Major Product Offerings
7.2.4 AbbVie Inc. Clinical Biomarker Testing Revenue in Global Market (2018-2023)
7.2.5 AbbVie Inc. Key News & Latest Developments
7.3 Adaptive Biotechnologies
7.3.1 Adaptive Biotechnologies Company Summary
7.3.2 Adaptive Biotechnologies Business Overview
7.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Major Product Offerings
7.3.4 Adaptive Biotechnologies Clinical Biomarker Testing Revenue in Global Market (2018-2023)
7.3.5 Adaptive Biotechnologies Key News & Latest Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Company Summary
7.4.2 Agilent Technologies Business Overview
7.4.3 Agilent Technologies Clinical Biomarker Testing Major Product Offerings
7.4.4 Agilent Technologies Clinical Biomarker Testing Revenue in Global Market (2018-2023)
7.4.5 Agilent Technologies Key News & Latest Developments
7.5 BD
7.5.1 BD Company Summary
7.5.2 BD Business Overview
7.5.3 BD Clinical Biomarker Testing Major Product Offerings
7.5.4 BD Clinical Biomarker Testing Revenue in Global Market (2018-2023)
7.5.5 BD Key News & Latest Developments
7.6 Becton Dickinson
7.6.1 Becton Dickinson Company Summary
7.6.2 Becton Dickinson Business Overview
7.6.3 Becton Dickinson Clinical Biomarker Testing Major Product Offerings
7.6.4 Becton Dickinson Clinical Biomarker Testing Revenue in Global Market (2018-2023)
7.6.5 Becton Dickinson Key News & Latest Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Company Summary
7.7.2 Bio-Rad Laboratories Business Overview
7.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Major Product Offerings
7.7.4 Bio-Rad Laboratories Clinical Biomarker Testing Revenue in Global Market (2018-2023)
7.7.5 Bio-Rad Laboratories Key News & Latest Developments
7.8 Danaher Corporation
7.8.1 Danaher Corporation Company Summary
7.8.2 Danaher Corporation Business Overview
7.8.3 Danaher Corporation Clinical Biomarker Testing Major Product Offerings
7.8.4 Danaher Corporation Clinical Biomarker Testing Revenue in Global Market (2018-2023)
7.8.5 Danaher Corporation Key News & Latest Developments
7.9 Merck and Co.
7.9.1 Merck and Co. Company Summary
7.9.2 Merck and Co. Business Overview
7.9.3 Merck and Co. Clinical Biomarker Testing Major Product Offerings
7.9.4 Merck and Co. Clinical Biomarker Testing Revenue in Global Market (2018-2023)
7.9.5 Merck and Co. Key News & Latest Developments
7.10 Thermofisher Scientific
7.10.1 Thermofisher Scientific Company Summary
7.10.2 Thermofisher Scientific Business Overview
7.10.3 Thermofisher Scientific Clinical Biomarker Testing Major Product Offerings
7.10.4 Thermofisher Scientific Clinical Biomarker Testing Revenue in Global Market (2018-2023)
7.10.5 Thermofisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com